Spark BioLab and Aegis Asset Management to Launch 'Life Sciences Real Estate Project'
Joint Development of Specialized Life Sciences Facilities
Spark BioLab, a subsidiary of Spark Lab Group, announced on the 17th that it has signed a business agreement with Aegis Asset Management to establish and operate dedicated infrastructure for life sciences companies.
This agreement aims to lay the foundation for the sustainable growth of the domestic life sciences industry by combining Spark BioLab's capabilities in nurturing biotech startups and managing spaces with Aegis Asset Management's expertise in real estate development and operations.
Hongju Lee, CEO of Spark BioLab, and Gwansik Yoon, Executive Director of Aegis Asset Management, are posing for a commemorative photo at the business agreement ceremony. Spark Lab
View original imageUnder the agreement, the two companies will jointly identify and develop facilities specialized for the life sciences industry, including research and laboratory spaces equipped with state-of-the-art equipment, clean rooms dedicated to clinical and preclinical testing, and ultra-low temperature logistics facilities for reagent and sample storage. These facilities will be provided to biotech startups at reasonable costs.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Hongju Lee, CEO of Spark BioLab, stated, "The growth of the biotech industry requires not only research and investment, but also advanced infrastructure. Through our collaboration with Aegis Asset Management, we will support domestic biotech startups so they can grow in a research and business environment that meets global standards."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.